Work

Randomized, placebo-controlled trial of atorvastatin to prevent hearing loss in patients with head and neck squamous cell carcinoma receiving cisplatin based chemoradiation (CRT).

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.16_suppl.tps12153

Authors: Nicole C. Schmitt, Katharine Fernandez, Shawn Newlands, Paul Allen, Adam Kaufman, Garnett P. McMillan, Jeffrey M. Switchenko, William A. Stokes, Ranee Mehra, Anant Mandawat, Robert Shamburek, Nabil F. Saba, Lisa L. Cunningham

Institutions: Emory University, National Institutes of Health, National Institute on Deafness and Other Communication Disorders, University of Rochester, University of Maryland, Baltimore, Emory University Hospital Midtown, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, National Heart, Lung, and Blood Institute, Winship Cancer Institute

Language: English

Topic: Chemotherapy-induced organ toxicity mitigation

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4400409482

Cites:

Cited by: 1

Related to: 10